Indo Us Biotech Limited has informed the Exchange regarding 'Submit the machine-readable of financial results for the period ended 31-Dec-2025.'.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has submitted the machine-readable (XBRL) version of its financial results for the quarter and nine months ended December 31, 2025 to the stock exchange. This is a routine regulatory filing required under SEBI's listing regulations, where companies upload their financial data in a digital format that can be easily read and processed by databases and analytics tools. The detailed financial results were typically filed as a separate announcement. No specific financial numbers or performance metrics are mentioned in this particular filing.
This is a procedural compliance filing and does not by itself signal any change in business performance or stock price. Shareholders should look at the separately filed detailed financial results to assess the company's actual quarterly performance.